At the biennial BritSpine 2014 conference; Max Reinhardt, worldwide president, DePuy Synthes Spine, spoke about the past, present and future outlook for spinal implant companies and spinal surgeons.
“Spinal disorders impact patients of all ages as well as the families who care for them. The associated costs are considerable and have been estimated to exceed €12billion annually in the European Union. Our primary aim at DePuy Synthes Spine is getting people back to doing the things they love, with the people they love, whilst reducing costs,” says Reinhardt.
During the key note presentation, Reinhardt, who has worked in the spinal industry for more than 12 years, recognised the significance of technological advancements from across the industry, yet highlighted the importance of adapting to current and future healthcare challenges.
“Identifying and addressing these challenges has brought new stakeholders to the table where payers, providers and policy makers influence treatment decisions along with physicians and patients,” adds Reinhardt. “We must now operate in this new environment with new perspectives in mind and tailor solutions to bring the most value to our customers.”
Later in the conference agenda Reinhardt participated in an industry panel discussion.
The Company showcased a selection of its solutions during the congress, and offered delegates the opportunity to learn more about how it’s minimally invasive spine (MIS), anterior cervical and adult deformity solutions can enhance patient outcomes whilst delivering value to health care professionals.
